ArticleBMJ oncology2024

Baseline tumour vessel perfusion as a non-invasive predictive biomarker for immune checkpoint therapy in non-small-cell lung cancer.

Zhenhua Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.